ANO2 and myeloid sarcoma: Elevated autoantibody reactivity to anoctamin 2 (ANO2), a Ca2+-activated chloride channel, has been detected in MS patients, with anti-ANO2 antibody levels being 5.3-fold higher compared to controls (84).